CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST - LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)

被引：0
|
作者：
Adda, B.
Farida, S.
机构：
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [1] CAPECITABINE AND IRINOTECAN (CAPIRI) AS FIRST -LINE TREATMENT FOR PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, A.
    Smail, F.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 67 - 68
  • [2] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (PTS) with metastatic colorectal cancer (MCRC)
    Laudani, Agata
    Savio, Giuseppina
    Leonardi, Vita
    Palmisano, Valentina
    Rondello, Giacomo
    Alu, Massimiliano
    Pepe, Alessio
    Calabria, Caterina
    Usset, Antonella
    Agostara, Biagio
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 119 - 119
  • [3] Capecitabine plus irinotecan (CAPIRI) as first-line treatment for patients (Pts) with metastatic colorectal cancer (MCRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Palmisano, V.
    Tartaglia, L.
    Manuguerra, G.
    Pepe, A.
    Alu, M.
    Usset, A.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 6 - 6
  • [4] EFFICACY AND SAFETY OF CAPECITABINE AND IRINOTECAN (CAPIRI) IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Bounedjar, Adda
    Smaili, Farida
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v99 - v99
  • [5] Capetabine plus irinotecan (CAPIRI) as first line treatment for patients with metastatic colorectal cancer(MCRC)
    Laudani, A.
    Alu, M.
    Leonardi, V
    Savio, G.
    Pepe, A.
    Palmisano, V
    Targaglia, L.
    Porretto, C.
    Manuguerra, G.
    Calabria, C.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII41 - VII41
  • [6] Capecitabine (X) plus weekly irinotecan (CAPIRI) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC): findings from a phase II trial of the Brazilian Oncology Consordium
    Barrios, Carlos Henrique
    Viola, Fabiana
    Coura, Luciana
    Del Giglio, Auro
    Malhias, Clarissa
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 89 - 90
  • [7] Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer
    Boers-Sonderen, M. J.
    Desar, I. M. E.
    Koopman, M.
    Punt, C. J.
    van Herpen, C. M. L.
    [J]. ACTA ONCOLOGICA, 2013, 52 (08) : 1778 - 1779
  • [8] Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)
    Salud, A.
    Escudero, P.
    Feliu, J.
    Lopez-Gomez, L.
    Bolanos, M.
    Galan, A.
    Yubero, A.
    Vicent, J. M.
    Losa, F.
    Gonzalez-Baron, M.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 190 - 190
  • [9] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [10] A phase II trial of a biweekly schedule of capecitabine (X) plus irinotecan (1) as first-line treatment in patients (pts) with metastatic colorectal cancer (MCRC).
    Garcia-Alfonso, P
    Perez-Manga, G
    Gonzalez, MC
    Lopez, P
    Gonzalez, E
    Belon, J
    Molina, M
    Pachon, V
    Iglesias, L
    Siso, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 256S - 256S
12345